Feifeng Li
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 5
- Co-authors
- Danqun Huo (3 shared papers)Changjun Hou (3 shared papers)Dong Zhao (2 shared papers)Jia Zheng (2 shared papers)Yi Ma (2 shared papers)Peng Zhao (2 shared papers)Huisi Yang (2 shared papers)Xu Ma (2 shared papers)
In The Last Decade
Feifeng Li
21 papers receiving 292 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 44
- Applied Microbiology and Biotechnology 11
- Bioengineering 20
- Endocrinology 17
- Electrochemistry 19
Countries citing papers authored by Feifeng Li
This map shows the geographic impact of Feifeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifeng Li more than expected).
Fields of papers citing papers by Feifeng Li
This network shows the impact of papers produced by Feifeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifeng Li. The network helps show where Feifeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 78 | |
| 2 | 2023 | 70 | |
| 3 | Mutation G61C in the CRYGD gene causing autosomal dominant congenital coralliform cataracts. | 2008 | 26 |
| 4 | 2021 | 25 | |
| 5 | 2010 | 19 | |
| 6 | 2015 | 13 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 10 | |
| 9 | 2021 | 8 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 8 | |
| 12 | 2018 | 8 | |
| 13 | 2018 | 5 | |
| 14 | 2021 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2018 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 1 |
About Feifeng Li
Feifeng Li is a scholar working on Molecular Biology, Molecular Medicine, Epidemiology, Endocrinology and Pharmacology, having authored 24 papers that have together received 300 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Electrochemical sensors and biosensors (3 papers), Vibrio bacteria research studies (2 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Antibiotic Use and Resistance (2 papers), Advanced Nanomaterials in Catalysis (2 papers) and Electrochemical Analysis and Applications (2 papers). The work is most often cited by research in Molecular Medicine (44 citations), Applied Microbiology and Biotechnology (11 citations), Bioengineering (20 citations), Endocrinology (17 citations) and Electrochemistry (19 citations). Feifeng Li has collaborated with scholars based in China, Thailand and Singapore. Frequent co-authors include Danqun Huo, Changjun Hou, Dong Zhao, Jia Zheng, Yi Ma, Peng Zhao, Huisi Yang, Xu Ma, Siquan Zhu and Baomo Liu. Their work appears in journals such as Antibiotics, Current Eye Research, BMC Microbiology, Emerging Microbes & Infections and Multimedia Tools and Applications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.